Related Experiment Video

Updated: Nov 10, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.9K

A new discovered gene mutation in a child with dilated cardiomyopathy

Xiaolong Chen1, Yewei Xie1, Xiaobing Li1

  • 1Department of Cardiothoracic Surgery, Shanghai Children's Hospital, Shanghai Jiao Tong University, Putuo District, Shanghai, China.

Cardiology in the Young
|April 5, 2021
PubMed

Insights

This study identifies a rare genetic link between dilated cardiomyopathy, the most common childhood heart condition, and specific mutations in the BMPR2 gene. This association has not been previously documented in medical literature.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatrics

Background:

  • Dilated cardiomyopathy (DCM) is the most frequent pediatric cardiomyopathy, defined by ventricular dilation and impaired contraction.
  • Genetic mutations are increasingly recognized as significant contributors to DCM.
  • The genetic underpinnings of many childhood cardiomyopathies remain incompletely understood.

Purpose of the Study:

  • To report a novel association between dilated cardiomyopathy and a specific genetic mutation.
  • To investigate the role of the BMPR2 gene in pediatric dilated cardiomyopathy.
  • To contribute to the understanding of genetic factors in childhood heart disease.

Main Methods:

  • Case report detailing a patient with dilated cardiomyopathy.
  • Genetic analysis to identify mutations.
  • Literature review to assess novelty of findings.

Main Results:

  • A rare association between dilated cardiomyopathy and a site mutation in the BMPR2 gene was identified.
  • This specific BMPR2 mutation association with DCM has not been previously reported in the scientific literature.
  • The findings suggest a potential new genetic pathway involved in pediatric DCM.

Conclusions:

  • The BMPR2 gene mutation represents a potential, previously unrecognized cause of dilated cardiomyopathy in children.
  • Further research is warranted to explore the functional impact of BMPR2 mutations in pediatric cardiac conditions.
  • This discovery highlights the importance of comprehensive genetic screening in diagnosing childhood cardiomyopathies.

Keywords:
BMPR2Dilated cardiomyopathychildgene mutation

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.0K
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

26.1K

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
125
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
121
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
185
Mutations01:39

Mutations

Overview
89.8K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
41.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
104